Vishnubhatla Sreenivas
- Hepatology top 1%
- Liver Disease and Transplantation 10
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Nephrology top 1%
- Infectious Diseases top 1%
- Tuberculosis Research and Epidemiology 14
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment 20
- Microscopic Colitis 11
- Gastroenterology top 2%
- Celiac Disease Research and Management 13
-
- Reproductive tract infections research 14
-
- Vitamin D Research Studies 11
- Co-authors
- Ravinder GoswamiGovind MakhariaNandita GuptaSubrat Kumar AcharyaBenu DhawanRama ChaudhryPramod Kumar GargSubrat Kumar Panda
- Journals
- New England Journal of Medicine (1 paper)The Lancet (2 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- IndiaUnited StatesUnited Kingdom
In The Last Decade
Vishnubhatla Sreenivas
255 papers receiving 6.7k citations
Peers
Comparison fields: 5 of 174
- Hepatology 696
- Nephrology 449
- Infectious Diseases 1.0k
- Epidemiology 1.9k
- Gastroenterology 237
Countries citing papers authored by Vishnubhatla Sreenivas
This map shows the geographic impact of Vishnubhatla Sreenivas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vishnubhatla Sreenivas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vishnubhatla Sreenivas more than expected).
Fields of papers citing papers by Vishnubhatla Sreenivas
This network shows the impact of papers produced by Vishnubhatla Sreenivas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vishnubhatla Sreenivas. The network helps show where Vishnubhatla Sreenivas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vishnubhatla Sreenivas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 2 | |
| 5 | 2021 | 5 | |
| 6 | 2020 | 15 | |
| 7 | 2020 | 3 | |
| 8 | 2020 | 9 | |
| 9 | 2019 | 15 | |
| 10 | 2018 | 4 | |
| 11 | 2018 | 1 | |
| 12 | 2017 | 2 | |
| 13 | 2017 | 6 | |
| 14 | 2014 | 63 | |
| 15 | Diagnostic efficacy of a real time-PCR assay for Chlamydia trachomatis infection in infertile women in north India | 2014 | 2 |
| 16 | Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity. | 2010 | 94 |
| 17 | Are metabolic syndrome, obstructive sleep apnoea & syndrome Z sequential?--a hypothesis. | 2010 | 7 |
| 18 | Proton magnetic resonance spectroscopy of brain in obstructive sleep apnoea in north Indian Asian subjects. | 2010 | 7 |
| 19 | 2009 | 15 | |
| 20 | 1996 | 180 |
About Vishnubhatla Sreenivas
Vishnubhatla Sreenivas is a scholar working on Gastroenterology, Hepatology and Epidemiology, having authored 269 papers that have together received 7.0k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (20 papers), Reproductive tract infections research (14 papers), Tuberculosis Research and Epidemiology (14 papers), Celiac Disease Research and Management (13 papers), Vitamin D Research Studies (11 papers), Microscopic Colitis (11 papers), Liver Disease and Transplantation (10 papers) and Hepatocellular Carcinoma Treatment and Prognosis (9 papers). The work is most often cited by research in Hepatology (696 citations), Nephrology (449 citations) and Infectious Diseases (1.0k citations). Vishnubhatla Sreenivas has collaborated with scholars based in India, United States and United Kingdom. Frequent co-authors include Ravinder Goswami, Govind Makharia, Nandita Gupta, Subrat Kumar Acharya, Benu Dhawan, Rama Chaudhry, Pramod Kumar Garg, Subrat Kumar Panda, Raju Sharma and Arti Kapil. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.